PHA Classroom banner

PHA Classroom has moved! Visit

>>Back to All Recordings

>>Back to About PH Recordings
>>Back to 2012 Conference Session Recordings

Session Recording from PHA's 2012 10th International PH Conference
PDE-5 Inhibitors and Endothelin Receptor Antagonists

June 23, 2012

This session will cover the phosphodiesterase inhibitors (PDE-5 inhibitors) (sildenafil, tadalafil) and their role in the treatment of pulmonary arterial hypertension. The mechanism of action of these drugs will be discussed as well as their potential benefits and associated risks. The evidence supporting their use will also be presented.

Presenter Information

Richard Channick, MD, Massachusetts General Hospital, Boston, Mass. (Chair); Adaani Frost, MD, Baylor College of Medicine, Houston, Texas; Sandra Lombardi, RN, UCSD Medical Center, Encinitas, Calif.; Srinivas Murali, MD, West Penn Allegheny Health System, Pittsburgh, Pa.








Actelion Pharmaceuticals US, Inc. Gilead Sciences, Inc. Bayer HealthCare United Therapeutics Corporation
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.


FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2016 Pulmonary Hypertension Association. All Rights Reserved.


The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.